182 related articles for article (PubMed ID: 20929434)
1. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of epirubicin hydrochloride long-circulating thermosensitive liposomes in rat plasma].
Wu Y; Zhang FC; Wu C; Mei XG; Lü WL
Yao Xue Xue Bao; 2010 Mar; 45(3):365-70. PubMed ID: 21351514
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
4. Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes.
Sha X; Guo J; Chen Y; Fang X
J Liposome Res; 2012 Mar; 22(1):80-8. PubMed ID: 22022836
[TBL] [Abstract][Full Text] [Related]
5. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
6. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
Tagami T; May JP; Ernsting MJ; Li SD
J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes upon Mild Hyperthermia in C26 Tumor Bearing BALB/c Mice.
Alavizadeh SH; Gheybi F; Nikpoor AR; Badiee A; Golmohammadzadeh S; Jaafari MR
Mol Pharm; 2017 Mar; 14(3):712-721. PubMed ID: 28135098
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
[TBL] [Abstract][Full Text] [Related]
9. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.
Gabizon AA
Cancer Res; 1992 Feb; 52(4):891-6. PubMed ID: 1737351
[TBL] [Abstract][Full Text] [Related]
10. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
11. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
Chelvi TP; Jain SK; Ralhan R
Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
17. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
[TBL] [Abstract][Full Text] [Related]
18. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Lo YL; Liu Y; Tsai JC
Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid.
Mayhew EG; Lasic D; Babbar S; Martin FJ
Int J Cancer; 1992 May; 51(2):302-9. PubMed ID: 1568796
[TBL] [Abstract][Full Text] [Related]
20. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
